22157.jpg
Ibrutinib Global Market Report 2024 - Ibrutinib Market Projected to Reach $41.98 Billion by 2028: In-depth Analysis Reveals North America Leads Growth
February 27, 2024 11:22 ET | Research and Markets
Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Ibrutinib Global Market Report 2024" has been added to ResearchAndMarkets.com's offering.The ibrutinib market size is expected to see exponential...
22157.jpg
Mantle Cell Lymphoma Therapeutics Market to Reach $3.29 Billion by 2028 with Innovations in Targeted Therapies
February 08, 2024 11:42 ET | Research and Markets
Dublin, Feb. 08, 2024 (GLOBE NEWSWIRE) -- The "Mantle Cell Lymphoma Therapeutics Global Market Report 2024" has been added to ResearchAndMarkets.com's offering. The latest market research report...
22157.jpg
The Launch of Emerging Therapies Will Significantly Impact the Waldenstrom Macroglobulinemia Market - Global Emerging Insights and Market Forecast to 2030
December 20, 2021 05:43 ET | Research and Markets
Dublin, Dec. 20, 2021 (GLOBE NEWSWIRE) -- The "Waldenstrom Macroglobulinemia - Market Insight, Epidemiology and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering....
22157.jpg
Global Follicular Lymphoma Market and Epidemiology Landscape Report 2021-2030 - Discover the Drivers, Barriers, and Unmet Medical Needs to Curate the Best Opportunities
December 17, 2021 07:13 ET | Research and Markets
Dublin, Dec. 17, 2021 (GLOBE NEWSWIRE) -- The "Follicular Lymphoma Market Insights, Epidemiology, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering. This report...
22157.jpg
Global Chronic Lymphocytic Leukemia (CLL) Disorder Clinical Market Report 2021-2027
July 06, 2021 08:08 ET | Research and Markets
Dublin, July 06, 2021 (GLOBE NEWSWIRE) -- The "Chronic Lymphocytic Leukemia (CLL)" report has been added to ResearchAndMarkets.com's offering. Chronic lymphocytic leukemia (CLL) is a disorder where...
22157.jpg
Global Mantle Cell Lymphoma Treatment Market (2021 to 2029) - Featuring Amgen, Astellas Pharma and Biogen Among Others
June 17, 2021 07:53 ET | Research and Markets
Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Mantle Cell Lymphoma Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...
22157.jpg
Global Waldenstrom Macroglobulinemia (WM) Market Spotlight Report 2021: Bristol Myers Squibb, Johnson & Johnson, and Takeda Lead Industry Sponsors with the Highest Overall Number of Clinical Trials
June 08, 2021 07:58 ET | Research and Markets
Dublin, June 08, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Waldenstrom Macroglobulinemia (WM)" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report covers...
22157.jpg
China Ibrutinib Markets, 2016-2020 & 2021-2025: A BTK Inhibitor Used to Treat B-cell Carcinomas
May 21, 2021 04:48 ET | Research and Markets
Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Ibrutinib Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Ibrutinib is a BTK inhibitor,...
22157.jpg
Global Follicular Lymphoma Market Insights, Epidemiology and Forecast 2017-2019 & 2020-2030
September 22, 2020 04:48 ET | Research and Markets
Dublin, Sept. 22, 2020 (GLOBE NEWSWIRE) -- The "Follicular Lymphoma - Market Insights, Epidemiology and Forecast to 2030" report has been added to ResearchAndMarkets.com's offering. Follicular...